These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 35249123)
1. Axillary lymph node dissection vs. sentinel node biopsy for early-stage clinically node-negative breast cancer: a systematic review and meta-analysis. Petousis S; Christidis P; Margioula-Siarkou C; Liberis A; Vavoulidis E; Margioula-Siarkou G; Vatopoulou A; Papanikolaou A; Mavromatidis G; Dinas K Arch Gynecol Obstet; 2022 Oct; 306(4):1221-1234. PubMed ID: 35249123 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety comparison between axillary lymph node dissection with no axillary surgery in patients with sentinel node-positive breast cancer: a systematic review and meta-analysis. Fan YJ; Li JC; Zhu DM; Zhu HL; Zhao Y; Zhu XB; Wu G; Bai TT BMC Surg; 2023 Jul; 23(1):209. PubMed ID: 37495945 [TBL] [Abstract][Full Text] [Related]
3. Recommendation for axillary lymph node dissection in women with early breast cancer and sentinel node metastasis: A systematic review and meta-analysis of randomized controlled trials using the GRADE system. Huang TW; Kuo KN; Chen KH; Chen C; Hou WH; Lee WH; Chao TY; Tsai JT; Su CM; Huang MT; Tam KW Int J Surg; 2016 Oct; 34():73-80. PubMed ID: 27562691 [TBL] [Abstract][Full Text] [Related]
4. Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: Long-term Follow-up From the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial. Giuliano AE; Ballman K; McCall L; Beitsch P; Whitworth PW; Blumencranz P; Leitch AM; Saha S; Morrow M; Hunt KK Ann Surg; 2016 Sep; 264(3):413-20. PubMed ID: 27513155 [TBL] [Abstract][Full Text] [Related]
5. The evolution of the sentinel node procedure in the treatment of breast cancer. Tvedskov TF Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975889 [TBL] [Abstract][Full Text] [Related]
6. Comparing Early-Stage Breast Cancer Patients with Sentinel Lymph Node Metastasis with and without Completion Axillary Lymph Node Dissection: A Systematic Review and Meta-Analysis. Heiranizadeh N; Rafiei Shahamabadi M; Dehghan HR; Jafari-Nedooshan J; Kargar S; Zare M; Amooei A; Shiryazdi SM; Broomand MA; Moravej MT; Sadri Z Asian Pac J Cancer Prev; 2022 Aug; 23(8):2561-2571. PubMed ID: 36037108 [TBL] [Abstract][Full Text] [Related]
7. Prediction of additional lymph node involvement in breast cancer patients with positive sentinel lymph nodes. Pohlodek K; Bozikova S; Meciarova I; Mucha V; Bartova M; Ondrias F Neoplasma; 2016; 63(3):427-34. PubMed ID: 26925789 [TBL] [Abstract][Full Text] [Related]
8. Nonsentinel Axillary Lymph Node Status in Clinically Node-Negative Early Breast Cancer After Primary Systemic Therapy and Positive Sentinel Lymph Node: A Predictive Model Proposal. Cebrecos I; Mension E; Alonso I; Castillo H; Sanfeliu E; Vidal-Sicart S; Ganau S; Vidal M; Schettini F Ann Surg Oncol; 2023 Aug; 30(8):4657-4668. PubMed ID: 36809608 [TBL] [Abstract][Full Text] [Related]
9. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Giuliano AE; McCall L; Beitsch P; Whitworth PW; Blumencranz P; Leitch AM; Saha S; Hunt KK; Morrow M; Ballman K Ann Surg; 2010 Sep; 252(3):426-32; discussion 432-3. PubMed ID: 20739842 [TBL] [Abstract][Full Text] [Related]
10. Axillary lymph node dissection vs sentinel biopsy only among women with early-stage breast cancer and sentinel node metastasis: A systematic review and meta-analysis. Peristeri DV; Harissis HV Breast J; 2021 Feb; 27(2):158-164. PubMed ID: 33368762 [TBL] [Abstract][Full Text] [Related]
11. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial. Giuliano AE; Ballman KV; McCall L; Beitsch PD; Brennan MB; Kelemen PR; Ollila DW; Hansen NM; Whitworth PW; Blumencranz PW; Leitch AM; Saha S; Hunt KK; Morrow M JAMA; 2017 Sep; 318(10):918-926. PubMed ID: 28898379 [TBL] [Abstract][Full Text] [Related]
12. Preservation of Axillary Lymph Nodes Compared with Complete Dissection in T1-2 Breast Cancer Patients Presenting One or Two Metastatic Sentinel Lymph Nodes: The SINODAR-ONE Multicenter Randomized Clinical Trial. Tinterri C; Gentile D; Gatzemeier W; Sagona A; Barbieri E; Testori A; Errico V; Bottini A; Marrazzo E; Dani C; Dozin B; Boni L; Bruzzi P; Fernandes B; Franceschini D; Spoto R; Torrisi R; Scorsetti M; Santoro A; Canavese G; Ann Surg Oncol; 2022 Sep; 29(9):5732-5744. PubMed ID: 35552930 [TBL] [Abstract][Full Text] [Related]
13. Axillary lymph node recurrence following wire-directed sentinel lymph node dissection for breast cancer patients with biopsy-proven axillary metastases prior to neoadjuvant chemotherapy at a safety net medical center. Sargent RE; Siegel E; Ito F; Kramme K; Kraft E; Hendrix V; Carr AA; Nelson ME; Bian SX; Jayachandran P; Sener SF J Surg Oncol; 2023 Jul; 128(1):9-15. PubMed ID: 36933187 [TBL] [Abstract][Full Text] [Related]
14. Axillary Lymph Node Dissection is Associated with Improved Survival Among Men with Invasive Breast Cancer and Sentinel Node Metastasis. Chung SH; de Geus SWL; Shewmaker G; Romatoski KS; Drake FT; Ko NY; Merrill AL; Hirsch AE; Tseng JF; Sachs TE; Cassidy MR Ann Surg Oncol; 2023 Sep; 30(9):5610-5618. PubMed ID: 37204557 [TBL] [Abstract][Full Text] [Related]
15. Long-term survival after sentinel lymph node biopsy or axillary lymph node dissection in pN0 breast cancer patients: a population-based study. Zheng Q; Luo H; Xia W; Lu Q; Jiang K; Hong R; Xu F; Wang S Breast Cancer Res Treat; 2022 Dec; 196(3):613-622. PubMed ID: 36207619 [TBL] [Abstract][Full Text] [Related]
16. Management of the Axilla in T1-2 Breast Cancer Patients with Macrometastatic Sentinel Node Involvement Who Underwent Breast-Conserving Therapy. Kuru B; Yuruker S; Sullu Y; Gursel B; Ozen N J Invest Surg; 2019 Jan; 32(1):48-54. PubMed ID: 28945489 [TBL] [Abstract][Full Text] [Related]
17. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. Giuliano AE; Hunt KK; Ballman KV; Beitsch PD; Whitworth PW; Blumencranz PW; Leitch AM; Saha S; McCall LM; Morrow M JAMA; 2011 Feb; 305(6):569-75. PubMed ID: 21304082 [TBL] [Abstract][Full Text] [Related]
18. Sentinel Lymph Node Biopsy Versus Axillary Dissection in Node-Negative Early-Stage Breast Cancer: 15-Year Follow-Up Update of a Randomized Clinical Trial. Canavese G; Bruzzi P; Catturich A; Tomei D; Carli F; Garrone E; Spinaci S; Lacopo F; Tinterri C; Dozin B Ann Surg Oncol; 2016 Aug; 23(8):2494-500. PubMed ID: 26975739 [TBL] [Abstract][Full Text] [Related]
19. Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study. Classe JM; Loaec C; Gimbergues P; Alran S; de Lara CT; Dupre PF; Rouzier R; Faure C; Paillocher N; Chauvet MP; Houvenaeghel G; Gutowski M; De Blay P; Verhaeghe JL; Barranger E; Lefebvre C; Ngo C; Ferron G; Palpacuer C; Campion L Breast Cancer Res Treat; 2019 Jan; 173(2):343-352. PubMed ID: 30343457 [TBL] [Abstract][Full Text] [Related]
20. Does the presence of sentinel lymph node macrometastases in breast cancer patients require axillary lymph node dissection?-Single-center analysis. Nowikiewicz T; Zegarski W; Pagacz K; Nowacki M; Morawiec-Sztandera A; Głowacka-Mrotek I; Sowa M; Biedka M; Kołacińska A Breast J; 2018 Sep; 24(5):724-729. PubMed ID: 29476570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]